SARS-CoV-2 serology in patients on biological therapy or apremilast for psoriasis: a study of 93 patients in the Italian red zone

S. M.A. Ahmed; M. Volontè; E. Isoletta; C. Vassallo; C. F. Tomasini; D. Lilleri; P. Zelini; V. Musella; C. Klersy; V. Brazzelli

doi:10.1111/jdv.17721

SARS-CoV-2 serology in patients on biological therapy or apremilast for psoriasis: a study of 93 patients in the Italian red zone

S. M.A. Ahmed, M. Volontè, E. Isoletta, C. Vassallo, C. F. Tomasini, D. Lilleri, P. Zelini, V. Musella, C. Klersy, V. Brazzelli

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	Journal of the European Academy of Dermatology and Venereology
DOIs	https://doi.org/10.1111/jdv.17721
Publication status	Accepted/In press - 2021

ASJC Scopus subject areas

Dermatology
Infectious Diseases

Access to Document

10.1111/jdv.17721

Cite this

Ahmed, S. M. A., Volontè, M., Isoletta, E., Vassallo, C., Tomasini, C. F., Lilleri, D., Zelini, P., Musella, V., Klersy, C., & Brazzelli, V. (Accepted/In press). SARS-CoV-2 serology in patients on biological therapy or apremilast for psoriasis: a study of 93 patients in the Italian red zone. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.17721

SARS-CoV-2 serology in patients on biological therapy or apremilast for psoriasis : a study of 93 patients in the Italian red zone. / Ahmed, S. M.A.; Volontè, M.; Isoletta, E.; Vassallo, C.; Tomasini, C. F.; Lilleri, D.; Zelini, P.; Musella, V.; Klersy, C.; Brazzelli, V.

In: Journal of the European Academy of Dermatology and Venereology, 2021.

Research output: Contribution to journal › Letter › peer-review

@article{763beec23a1f4a8589bb154bfcbcdb70,

title = "SARS-CoV-2 serology in patients on biological therapy or apremilast for psoriasis: a study of 93 patients in the Italian red zone",

author = "Ahmed, {S. M.A.} and M. Volont{\`e} and E. Isoletta and C. Vassallo and Tomasini, {C. F.} and D. Lilleri and P. Zelini and V. Musella and C. Klersy and V. Brazzelli",

year = "2021",

doi = "10.1111/jdv.17721",

language = "English",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "wiley",

}

TY - JOUR

T1 - SARS-CoV-2 serology in patients on biological therapy or apremilast for psoriasis

T2 - a study of 93 patients in the Italian red zone

AU - Ahmed, S. M.A.

AU - Volontè, M.

AU - Isoletta, E.

AU - Vassallo, C.

AU - Tomasini, C. F.

AU - Lilleri, D.

AU - Zelini, P.

AU - Musella, V.

AU - Klersy, C.

AU - Brazzelli, V.

PY - 2021

Y1 - 2021

UR - http://www.scopus.com/inward/record.url?scp=85117012449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85117012449&partnerID=8YFLogxK

U2 - 10.1111/jdv.17721

DO - 10.1111/jdv.17721

M3 - Letter

AN - SCOPUS:85117012449

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

ER -

SARS-CoV-2 serology in patients on biological therapy or apremilast for psoriasis: a study of 93 patients in the Italian red zone

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this